Navigation Links
UNC study firms up promise of potential new cervical cancer screening tool
Date:5/21/2008

CHAPEL HILL New research into the causes of cervical cancer appears to lend weight to the promise of a potential early detection method that could help prevent the disease.

According to a study involving scientists from the University of North Carolina at Chapel Hill, persistent infection with human papillomavirus (HPV) could be a useful clinical marker for increased risk of cervical cancer, the second most common cancer in women worldwide.

HPV is a sexually transmitted virus that can cause high-grade cervical lesions, increasing a womans risk of developing invasive cervical cancer.

Currently, Pap smear tests are widely used in screening programs aimed at detecting changes in the cervix before a cancer develops. However, testing for HPV infections has the potential to be more sensitive for future cervical cancer screening programs.

In the study thought to be the first of its kind and published online in the American Journal of Epidemiology scientists reviewed 41 existing studies including over 22,500 women to systemically evaluate the association between HPV persistence and high-grade lesions or cervical cancer.

Jennifer Smith, Ph.D., research assistant professor of epidemiology in the UNC School of Public Health and senior author of the paper, said: We found that a persistent HPV infection of six months to one year was consistently associated with a womans increased risk of high-grade cervical lesions or cervical cancer.

Smith is also a member of the UNC Lineberger Comprehensive Cancer Center.

There are approximately 14 high-risk types of HPV that cause invasive cervical cancer. The two most common types are 16 and 18, which have different viral genetic patterns. These virus types are responsible for about 70 percent of invasive cervical cancer and 50 percent of high-grade lesions worldwide.

The next step will be to develop a consensus definition of HPV persistence that can then u
'/>"/>

Contact: Patric Lane
patric_lane@unc.edu
919-962-8596
University of North Carolina at Chapel Hill
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50
2. Study presented at DDW 2008 Confirms that New Device Significantly Improves Detection of Polyps in the Colon
3. Israeli study finds obstructive sleep apnea is health factor from day 1
4. Study finds that recalled Aqua Dots did contain poisonous chemical
5. Study reveals link among childhood allergies, asthma symptoms, and early life exposure to cats
6. Study analyzed SYMBICORT in children with persistent asthma
7. New patient satisfaction study with budesonide/formoterol combination therapy
8. Study: Doctors not always sure when to treat BP in people with diabetes
9. Study concludes no racial disparities in long-term outcomes in recipients of liver transplants
10. Study: Doctors Not Always Sure When to Treat Blood Pressure in People With Diabetes
11. JAMA publication features study on depression and head and neck cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)...RUZ, CA--New connections begin to form between bra... task, according to a study published this week in... California, Santa Cruz, the study involved detail...e place in the brain during motor learning. , Th... reach through a slot to get a seed. They observed...
(Date:11/29/2009)...s unaware the sleep disorder boosts urine producti...althDay News) -- People who wake up during the nig...ogical problem. Sleep apnea, a breathing-related s...y suggests that nighttime urination, or nocturia, ...ructive sleep apnea, a disorder in which soft tiss...
(Date:11/28/2009)..., CHICAGO, Nov. 28 Get ready for...e in the clinical routine when Siemens introdu...sembly and Annual Meeting of the Radiological Soci...cember 3 at McCormick Place (Booth #825, East Buil...syngo. via , Siemens, new imaging software fo...
(Date:11/27/2009)..., BEDFORD, Mass., Nov. 27 /PRNewswire-FirstCall/ -..."), a supplier of precision technology products an...nnual meeting of the Company,s shareholders has be... and location of the meeting will be announced in ...received a requisition notice from Stephen Bershad...
(Date:11/27/2009)...SAN FRANCISCO, Nov. 27 T... that Blair Lambert, CFO/COO, will present at the ...ld at the May Fair Hotel in London, England, on We..., To listen to a live broadcast of The Gymboree Co... log on to www.gymboree.com, click on "Our Company...
Breaking Medicine News(10 mins):Health News:Study shows new brain connections form rapidly during motor learning 2Health News:Study shows new brain connections form rapidly during motor learning 3Health News:Sleep Apnea May Cause Nighttime Urination 2Health News:Sleep Apnea May Cause Nighttime Urination 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5Health News:GSI Group Calls Shareholders Meeting 2
...f investigators led by St. Jude Children’s Researc...treatment of the childhood brain cancer medullobla...urvival of children with this disease. The t... and raised the rate of survival among the 48 high...
People who have a low response to alcohol or the so called ability to
...edicine as a specialty in New Zealand may no longe...ecommendation by the Medical Council comes into fo...opportunity of working with breast physicians unde... are unable to seek employment in breast clinics. ...
... proposal for prevention of chikungunya and dengue...rectorate of Public Health//. Aedes aegypti, m...causing virus and dengue causing virus. Hence, the...e will be examined. According to P. Padmanabha...
...D--A dart-like molecule that sticks to proteins in...wth of blood vessels, according to researchers at... Clinic Cole Eye Institute. //Uncontrolled blood v...r 65 in the United States. Robert Salomon and...
... inactivity, depression and falls all increase ris...rgeting falls may be a particularly effective way ...ding to a new study. Fall-prevention efforts ...ers led by Vicki Freedman, Ph.D., a professor at t...
Other Medicine News:Health News:Improved Treatment Raises Medulloblastoma Survival Rate 2Health News:Molecule responsible for age associated macular degeneration identified 2Health News:Preventing Falls May Be Key to Avoiding Disability in Elderly 2
(Date:11/25/2009)... , EXTON, Pa., Nov. 25 BioTren...aunchTrends(TM) : Stelara report, the first i... tracking the launch of Centocor Ortho-Biotech,s S...months of availability. Each wave of the report p...rmatologists and qualitative information from a su...
(Date:11/25/2009)... , BASKING RIDGE, N.J., Nov. 25 /PRNewswire/ -...ding the development of antithrombotic aptamers wi...zo, PhD, CEO and President, will be presenting at ...ce at the New York Palace Hotel in New York City. ...(EST) on Tuesday, December 1 and will include an o...
(Date:11/25/2009)... , EAST BRUNSWICK, N.J., Nov. 25 /PRNewswire...cturer of direct digital Radiography ( ddR ) syste...acquired by a private Swiss Investor with a long t...g brand. The acquisition included all assets and i...entory. After 25 years of success and growth Swiss...
Breaking Medicine Technology:Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Swissray International Announces New Ownership 2Obesity Contributes to Rapid Cartilage Loss 51575 1Obesity Contributes to Rapid Cartilage Loss 51575 2Obesity Contributes to Rapid Cartilage Loss 51575 3Obesity Contributes to Rapid Cartilage Loss 51575 4Elbit Imaging Ltd Announces Swiss Team Uses InSightecs ExAblate 28R 29 4000 Brain System to Treat Patients With Functional Brain Disorders 4721 1Elbit Imaging Ltd Announces Swiss Team Uses InSightecs ExAblate 28R 29 4000 Brain System to Treat Patients With Functional Brain Disorders 4721 2Elbit Imaging Ltd Announces Swiss Team Uses InSightecs ExAblate 28R 29 4000 Brain System to Treat Patients With Functional Brain Disorders 4721 3Elbit Imaging Ltd Announces Swiss Team Uses InSightecs ExAblate 28R 29 4000 Brain System to Treat Patients With Functional Brain Disorders 4721 4Simulating medical situations helps students learn retain basic science concepts 51568 1Simulating medical situations helps students learn retain basic science concepts 51568 2
...Shows ADHD Patch Provides Tolerable and Effective ... SHP, Nasdaq:,SHPGY, TSX: SHQ), the global special...from a 12-month study of DAYTRANA(TM) (methylpheni...peractivity Disorder (ADHD),patch, demonstrated th...,and symptom control improvement in children aged ...
...umor Activity of NKTR-102 Associated With Increase... Active Metabolite of Irinotecan, SAN FRANCISCO, ...ented positive preclinical data today on its propr... at the AACR-NCI-EORTC,International Conference in...lighted the anti-tumor activity and unique pharmac...
Other Medicine Technology:Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system) 2Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system) 3Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system) 4Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system) 5NKTR-102 (PEG-Irinotecan) Demonstrates Significant Tumor Growth Inhibition In Multiple Preclinical Tumor Models 2NKTR-102 (PEG-Irinotecan) Demonstrates Significant Tumor Growth Inhibition In Multiple Preclinical Tumor Models 3NKTR-102 (PEG-Irinotecan) Demonstrates Significant Tumor Growth Inhibition In Multiple Preclinical Tumor Models 4NKTR-102 (PEG-Irinotecan) Demonstrates Significant Tumor Growth Inhibition In Multiple Preclinical Tumor Models 5
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
Medicine Products: